Atelerix Ltd

Atelerix is a new company based at the Babraham Research Campus in Cambridge and spunout from the research of BBSRC researcher Che Connon at the University of Newcastle.

Atelerix is commercialising a patented simple, low cost system capable of preserving the viability and functionality of cells at hypothermic temperatures (4°C to 21°C). Used as a method of cell storage and transport, it overcomes the acknowledged problems associated with cryo- shipping. Cells are encapsulated by in situ formation of the gel for shipping in plates or vials, and can be rapidly released from the gel by the addition of a simple buffer.

 

Associated Team Members

Relevant News

Sanj Kumar joins Atelerix as Chief Business Officer

November 18th 2019 — Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and transport of cells at room temperature, announced today that it has significantly expanded and strengthened…

Read More

Atelerix Consortium Awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies

Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and transport of cells at room temperature, today announces that it has been awarded a grant of £267,000…

Read More

Atelerix Raises Follow-on Funding Round of £700,000

Cell encapsulation for transport of cells and tissues at room temperature 9th May 2019 — Cambridge and Newcastle, UK – Atelerix, creators of an innovative cell encapsulation technology, today…

Read More

Atelerix Raises Seed Round

Cell encapsulation start-up enables the shipment of human cells at room temperature, overcoming problems of cryo-shipping 30 April 2018 — Cambridge and Newcastle, UK –– Atelerix, a spin-out from…

Read More
Show More